InvestmentCo-led CREATE Medicines $122M Series B financing to advance in vivo CAR therapies.CREATE MedicinesCREATE MedicinesNewpath Partnersprnewswire.comMAY 14, 2026MAY 14, 2026
InvestmentParticipated in Leal Therapeutics' $30M Series A financing for neuro-metabolic CNS therapeutics.Leal Therapeutics